科研之友
微信
新浪微博
Facebook
分享链接
摘要
A scalable and practical route to wogonin, a bioactive natural product with multiple pharmacological activities which is currently under phase I/II clinical studies, is described. Wogonin was obtained via a four-step process starting from commercially available chrysin and including the Elbs oxidation, benzylation, methylation, and the final debenzylation. The whole procedure gives the target product in a 38% overall yield with >99% purity. Key steps in this process including oxidation and methylation are discussed in detail. The optimized process has been successfully demonstrated on the kilogram scale to support ongoing clinical development of wogonin.
- 出版日期2017-2
- 单位中国药科大学
